. The level of GAPDH mRNA was used for normalization. Data are shown as means ± SD (n=3 technical replicates), and similar results were obtained from two independent experiments. d and e, Western blot of WCL of LNCaP cells transfected with control siRNA (siC) or a pool of SPOPspecific siRNAs for 48 h and then treated with 50 μg/ml cycloheximide (CHX) and harvested at different time points (d). At each time point, the intensity of each BET protein was normalized to the intensity of actin and then to the value at 0 h (e). Similar results were obtained from two independent experiments. f, RT-qPCR measurement of SPOP and BRD2/3/4 mRNA expression in LNCaP cells at 48 h after transfected with control and SPOP-specific siRNAs. Data are shown as means ± SD (n=3 technical replicates), and similar results were obtained from two independent experiments. g, Western blot of WCL of 293T cells transfected with indicated plasmids. h, Western blot of the products of in vivo ubiquitination assay performed by using cell lysate from 293T cells transfected with indicated plasmids and treated with 20 μM of MG132 for 8 h. K48O, K48-only ub, K63O, K63-only ub. i, Western blot of the products of in vivo ubiquitination assay performed by using anti-Ub or Ub-linkage specific (K48, K63) antibodies. Supplementary Figure 3│SPOP knockdown and expression prostate cancer-associated mutant promote JQ1-resistant growth of prostate cancer cells. a, Western blot of WCL from C4-2 cells infected with lentivirus expressing control shRNA (shC) or SPOP-specific shRNA #2 or #4 and treated with or without JQ1 (1 μM) for 24 h. β-tubulin was used as a loading control. b and c, C4-2 cells was infected with lentivirus as in (a) and then treated with or without JQ1 (0.25 μM) every other day. Cell growth was measured at indicated time points by cell proliferation assay (b) and trypan blue assay (c). Data are shown as means ± SD (n = 6 biological replicates). d and e, C4-2 cells infected with lentivirus expressing empty vector (EV) or SPOP F133V mutant in combination with control shRNA (shC), or BRD2/3/4 specific shRNAs. Cells were used for western blot analysis of indicated proteins in whole-cell lysate (d) or for analysis of cell growth measured by cell proliferation assay (left panel) and trypan blue assay (right panel) at indicated time points (e). β-tubulin was used as a loading control. Data are shown as means ± SD (n = 6). Statistical significance was determined by two-tailed Student's t-test for cells treated with JQ1 at day 4. f and g, 22Rv1 cells infected with lentivirus expressing empty vector (EV) or SPOP F133V mutant in combination with control shRNA (shC), or BRD2/3/4 specific shRNAs. Cells were used for western blot analysis of indicated proteins in whole-cell lysate (f) or for analysis of cell growth measured by cell proliferation assay (left panel) and trypan blue assay (right panel) at indicated time points (g). β-tubulin was used as a loading control. Data are shown as means ± SD (n = 6). Statistical significance was determined by two-tailed Student's t-test for cells treated with JQ1 at day 4. h-j, C4-2 cells were transfected with control siRNA (siC), a pool of BRD4-and/or SPOP specific siRNAs (siBRD4 or siSPOP) as indicated. At 48 h after transfection, the first set of cells were harvested for measurement of BRD4 and SPOP mRNA expression by RT-qPCR (h); the second set of cells were harvested for measurement of BRD4 and SPOP protein expression by western blots (i); the third set of cells were treated with different doses of JQ1 for 24 h and cell viability were measured by MTS assay (j). Data are shown in (h) as means ± SD (n = 3 technical replicates), and similar results were obtained from two independent experiments. Data are shown in (j) as means ± SD (n = 6 replicates). Comparison of the data in cells treated with the highest concentration (500 nM) of JQ1. k and l, BRD4 KO C4-2 cells were transfected with control siRNA (siC), pool of SPOP-specific siRNAs and/or BRD2/3 shRNAs (shBRD2/3 or siSPOP) as indicated. At 48 h after transfection, the first set of cells were harvested for measurement of BRD2/3/4 and SPOP protein expression by western blots; the second set of cells were treated with different doses of JQ1 for 24 h and cell growth were measured by cell proliferation assay. Data are shown as means ± SD (n = 6 replicates). Statistical significance was determined by two-tailed Student's t-test for cells treated with the highest concentration (500 nM) of JQ1. m, Western blot of indicated proteins including AKT (Ser473) and S6K (Thr389) phosphorylation in WCL of C4-2 (left) and 22Rv1 (right) cells infected with lentivirus expressing empty vector (EV) or SPOP F133V mutant and treated with vehicle (DMSO) or 1 μM JQ1 for 24 h. Western blot signal intensity of p-AKT and p-S6K was first normalized to pan AKT and S6K level, respectively and the value was further normalized to the one in cells infected with EV without JQ1 treatment. Asterisk in red indicates the exogenous HA-SPOPF133V. n, C4-2 (top panels) and 22Rv1 (bottom panels) cells were infected with lentivirus as in (m) and then treated with or without JQ1 (0.25 μM) every other day. Cell growth was measured by cell proliferation assay (left panels) and trypan blue assay (right panels). Data are shown as means ± SD (n = 6 biological replicates). o, Western blot of indicated proteins in WCL of C4-2 cells infected with indicated lentivirus for 48 h. p, C4-2 cell infected with lentivirus as in (o) were treated with vehicle (DMSO) or i-BET762 (i-BET, 0.5 μM) every other day and cell growth were measured by trypan blue assay at indicated time points. Data are shown as means ± SD (n = 6 biological replicates). q, 22Rv1 cells was infected with lentivirus as in (m) and then treated with or without i-BET (0. 5 μM) every other day. Cell growth was measured by trypan blue assay at indicated time points. Data are shown as means ± SD (n = 6 biological replicates).
All data are shown as mean values ± SD (n=3 technical replicates), and similar results were obtained from two independent experiments. i, Western blot analysis of indicated proteins in whole cell lysate of C4-2 cells infected with empty vector (EV) or SPOP F133V or BRD2/3/4 expressed vectors for 48 h before harvested. j, ChIP-qPCR analysis of H3K27ac, H4K5ac and H4K8ac binding at the RAC1 promoter of the indicated genes in C4-2 cells transfected with empty vector (Control), SPOP F133V or BRDs. All data shown are mean values ± SD (error bar) from three replicates. k and l, RT-qPCR (k) and western blot (l) analysis of RAC1 expression in C4-2 cells infected with lentivirus as indicated. The expression level of RAC1 mRNA was first normalized to the level of GAPDH mRNA (internal control) and then further normalized to the value in control (EV-shC) C4-2 cells. Data are shown as mean values ± SD (n=3 technical replicates), and similar results were obtained from two independent experiments. Comparing to the data in control (EV-shC) C4-2 cells. m, RT-qPCR analysis of RAC1 mRNA expression in C4-2 infected with lentivirus and JQ1 as in (a). RAC1 mRNA level was first normalized to the level of GAPDH mRNA and then further normalized to the value in EV-expressed C4-2 cells treated with vehicle. Data are shown as means ± SD (n=3 technical replicates), and similar results were obtained from two independent experiments. Two-tailed Student's ttest was used. n, Western blot of WCL of C4-2 cells infected with lentivirus as indicated and treated with JQ1 (1 μM) for 24 h before harvested. Western blot signal intensity RAC1 was first normalized to β-tubulin level and the value was further normalized to the one in control cells. o, Western blot of WCL of C4-2 cells infected with lentivirus expressing empty vector (EV) or SPOP-F133V in combination with control shRNA (shC) or RAC1-specific shRNAs and treated with or without JQ1 (1 μM) for 24 h before harvested. p, C4-2 cells were infected with lentivirus as in (o) and treated with JQ1 (0.25 μM) every other day. Cell growth was measured by cell proliferation assay. Data are shown as means ± SD (n=6 biological replicates).
